Beneficial effects of administering intraportal prostaglandin E1 postoperatively to hepatectomy patients with massive intraoperative blood loss

Surgery Today

Volumn 26, Issue 11, 1996, Pages 895-899

  Katsuramaki, Tadashi ^a   Mukaiya, Mitsuhiro ^a   Yamashiro, Kazuhiro ^a   Kimura, Hiromichi ^a   Denno, Ryuichi ^a   Hirata, Koichi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

hepatectomy; intraoperative blood loss; portal administration; prostaglandin E1

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; PROSTAGLANDIN E1;

ADULT; ARTICLE; BLEEDING; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; INTRAVENOUS DRUG ADMINISTRATION; LIVER FUNCTION TEST; LIVER RESECTION; MALE; PORTAL VEIN; POSTOPERATIVE CARE; SURGICAL PATIENT;

EID: 0029860862     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00311791     Document Type: Article

References (16)

1. Shimada M, Matsumata T, Akazawa K, Kamakura T, Itasaka H, Sugimachi K, Nose Y (1994) Estimation of risk of major complications after hepatic resection. Am J Surg. 167:399-403
2. Robert A (1979) Cytoprotection by prostaglandins. Gastroenterology 77:761-767
3. Stachura J, Tarnawski A, Ivey KJ, Mach T, Bogdal J, Szczudrawa J, Klimczyk B (1981) Prostaglandin protection of carbon tetrachloride-induced liver cell necrosis in the rat. Gastroenterology 81:211-217
4. 2 on ischemia-induced hepatic cell injury. Transplantation 36:238-243
5. 1 on the liver and kidney. Prostaglandins 21(Suppl):97-102
6. 1 on cholestasis and liver function after abdominal surgery (in Japanese). Gendai Iryou (Modern medical treatment) 24:3481-3788
7. Ferreria SH, Vane JR (1967) Prostaglandins: Their disappearance from and release into the circulation. Nature 216:868
8. 1). Hepatology (Baltimore) 7:1104
9. Sinclair SB, Greig PD, Blendis LM, Abecassis M, Roberts EA, Phillips MJ, Cameron R, Levy G (1989) Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report. J Clin Invest 84:1063-1069
10. 2: favorable effects on rat liver injury. Gastroenterology 102:572-576
11. 1 in an experimental massive hepatic cell necrosis model. Hepatology 7:1184-1187
12. 1 inhibits tumor necrosis factor production by Kupffer cells and prevents endotoxin induced mortality in mice. Gastroenterology 102:A846
13. Traverso LW, O'Benar ID, Buchalter CC (1984) Prostacyclin increases portal venous flow. Prostalandins 28:679-693
14. 2 on the rat mesentery in vitro and in vivo. Prostaglandins Leukotrienes Medicine 10:257-268
15. 1: Its effects on hepatic circulation in dog. Pharmacology 9:336-347
16. 1 abrogates early reductive stress and zone-specific paradoxical oxidative injury in hypoperfused rat liver. J Clin Invest 93:155-164